Biogen BIIB Product revenue, net — Total Revenue

Other product segments

Similar metrics at other companies

CRNXProduct revenue, net — Total Revenue

$10.31M—

CRMDProduct sales, net — Total Revenue

$121.92M+212%

GERNProduct revenue, net — Total revenues

$51.77M+31.3%

XER

XERSProduct revenue, net — Product revenue, net

$82.45M+42.6%

AGIOProduct revenue, net — Total Revenue

$20.75M+138%

ARDXProduct sales, net — Total revenues

$93.37M+37.7%

Questions, answered.

What is Biogen's product revenue, net — total revenue?

Biogen (BIIB) reported product revenue, net — total revenue of $1.75B in Q1 2026.

How has Biogen's product revenue, net — total revenue changed year-over-year?

Biogen's product revenue, net — total revenue increased by 1.5% year-over-year, from $1.73B to $1.75B.

What is the long-term trend for Biogen's product revenue, net — total revenue?

Over 4 years (2021 to 2025), Biogen's product revenue, net — total revenue has grown at a -5.3% compound annual growth rate (CAGR), from $8.85B to $7.12B.

What does product revenue, net — total revenue mean?

This metric represents the total net sales generated from the company's portfolio of pharmaceutical products after accounting for returns, rebates, and discounts. It serves as the primary indicator of market demand and commercial success for the company's core therapeutic offerings. Tracking this figure allows investors to assess the revenue-generating capacity of the company's marketed drug pipeline.